TRIDENT LIFELINE
Back to Income Statement
|
TRIDENT LIFELINE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹12 Cr | ₹6.34 Cr | ₹6.02 Cr | ₹3.95 Cr |
What is the latest Consolidated Net Profit of TRIDENT LIFELINE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹6.34 Cr |
| Mar2023 | ₹6.02 Cr |
| Mar2022 | ₹3.95 Cr |
How is Consolidated Net Profit of TRIDENT LIFELINE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | 85.18 | |
| Mar2024 | ₹6.34 Cr | 5.47 | |
| Mar2023 | ₹6.02 Cr | 52.36 | |
| Mar2022 | ₹3.95 Cr | - | |
Compare Consolidated Net Profit of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹312.4 Cr | 0.6% | 6.6% | -4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 0.6% |
6.6% |
-4.8% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses